| Long-term health outcomes of people living with spina bifida Centers for Disease Control - NCBDDD · CDC-RFA-DD-26-0222 | States, Counties, Cities & townships +9 | $3.0M | Oct 26, 2026 |
| HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) National Institutes of Health · PAR-27-045 | States, Counties, Cities & townships +12 | — | Oct 30, 2026 |
| GREGoRi Innovation Projects (U01 Clinical Trial Optional) National Institutes of Health · RFA-HG-27-013 | States, Counties, Cities & townships +12 | $7.5M | Oct 30, 2026 |
| GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed) National Institutes of Health · RFA-HG-27-011 | States, Counties, Cities & townships +12 | $2.0M | Oct 30, 2026 |
| GREGoRi Technology Integration Center (U01, Clinical Trials Optional) National Institutes of Health · RFA-HG-27-012 | States, Counties, Cities & townships +12 | $3.0M | Oct 30, 2026 |
| National Indian Health Outreach and Education Indian Health Service · HHS-2026-IHS-NIHOE-0001 | Tribal governments, Tribal organizations, Nonprofits (501c3) +1 | $1.1M | Nov 2, 2026 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) National Institutes of Health · PAR-24-279 | States, Counties, Cities & townships +12 | — | Nov 2, 2026 |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) National Institutes of Health · PAR-24-280 | States, Counties, Cities & townships +12 | — | Nov 2, 2026 |
| US Travelers Health Research, Surveillance, Communication, and Outreach Network Centers for Disease Control and Prevention - ERA · RFA-CK-26-036 | States, Counties, Cities & townships +10 | $5.0M | Nov 5, 2026 |
| Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases Centers for Disease Control and Prevention - ERA · RFA-CK-26-035 | States, Counties, Cities & townships +10 | $30.0M | Nov 5, 2026 |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-255 | States, Counties, Cities & townships +12 | — | Nov 5, 2026 |
| Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) National Institutes of Health · RFA-DK-27-125 | Others | $1.9M | Nov 6, 2026 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-095 | States, Counties, Cities & townships +12 | $350K | Nov 6, 2026 |
| Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) National Institutes of Health · RFA-DK-27-139 | Others | $1.8M | Nov 9, 2026 |
| Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) National Institutes of Health · RFA-DK-27-112 | Others | $6.3M | Nov 9, 2026 |
| Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed) National Institutes of Health · RFA-RM-27-024 | States, Counties, Cities & townships +12 | $2.0M | Nov 10, 2026 |
| Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) National Institutes of Health · RFA-OD-27-009 | Public universities, Nonprofits (501c3), Nonprofits (other) +1 | $5.0M | Nov 10, 2026 |
| Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) National Institutes of Health · RFA-AG-27-010 | States, Counties, Cities & townships +12 | $2.5M | Nov 10, 2026 |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) National Institutes of Health · RFA-AI-27-002 | States, Counties, Cities & townships +12 | $10.0M | Nov 10, 2026 |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) National Institutes of Health · RFA-AI-27-005 | States, Counties, Cities & townships +12 | $18.0M | Nov 10, 2026 |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) National Institutes of Health · RFA-CA-27-001 | States, Counties, Cities & townships +12 | $5.1M | Nov 10, 2026 |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) National Institutes of Health · RFA-CA-27-002 | States, Counties, Cities & townships +12 | $5.9M | Nov 10, 2026 |
| Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) National Institutes of Health · RFA-NS-26-001 | States, Counties, Cities & townships +12 | $40.0M | Nov 10, 2026 |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) National Institutes of Health · PAR-25-269 | States, Counties, Cities & townships +12 | $350K | Nov 13, 2026 |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) National Institutes of Health · PAR-25-270 | States, Counties, Cities & townships +12 | $1.1M | Nov 13, 2026 |
| NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) National Institutes of Health · PAR-25-271 | States, Counties, Cities & townships +12 | $350K | Nov 13, 2026 |
| NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) National Institutes of Health · PAR-24-089 | States, Counties, Cities & townships +12 | — | Nov 13, 2026 |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) National Institutes of Health · PAR-25-370 | States, Counties, Cities & townships +12 | — | Nov 16, 2026 |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) National Institutes of Health · RFA-DK-27-122 | States, Counties, Cities & townships +12 | — | Nov 17, 2026 |
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) National Institutes of Health · PAR-25-158 | States, Counties, Cities & townships +12 | — | Nov 17, 2026 |
| Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) National Institutes of Health · PAR-25-274 | States, Counties, Cities & townships +12 | — | Nov 17, 2026 |
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) National Institutes of Health · PAR-25-267 | States, Counties, Cities & townships +12 | — | Nov 17, 2026 |
| Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) National Institutes of Health · PAR-25-268 | States, Counties, Cities & townships +12 | — | Nov 17, 2026 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) National Institutes of Health · PAR-25-096 | States, Counties, Cities & townships +12 | $200K | Nov 17, 2026 |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) National Institutes of Health · PAR-25-371 | States, Counties, Cities & townships +12 | — | Nov 18, 2026 |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) National Institutes of Health · PAR-25-369 | States, Counties, Cities & townships +12 | — | Nov 18, 2026 |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) National Institutes of Health · PAR-25-226 | States, Counties, Cities & townships +12 | — | Nov 19, 2026 |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) National Institutes of Health · PAR-25-052 | States, Counties, Cities & townships +12 | — | Nov 19, 2026 |
| Preschool Development Grant Birth Through Five (PDG B-5) SMART Grant Administration for Children and Families · HHS-2026-ACF-ECD-TP-0039 | States, Others | $224.0M | Nov 20, 2026 |
| Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) National Institutes of Health · RFA-RM-27-025 | States, Counties, Cities & townships +12 | $3.0M | Nov 23, 2026 |
| Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) National Institutes of Health · RFA-RM-27-007 | States, Counties, Cities & townships +12 | $6.0M | Nov 23, 2026 |
| Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) National Institutes of Health · RFA-RM-27-016 | States, Counties, Cities & townships +12 | — | Nov 23, 2026 |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) National Institutes of Health · RFA-AT-25-003 | Public universities, Private universities, Others | — | Nov 23, 2026 |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) National Institutes of Health · PA-23-317 | States, Counties, Cities & townships +12 | — | Nov 24, 2026 |
| National Center for Construction Safety and Health Research and Translation (U54) Centers for Disease Control and Prevention - ERA · RFA-OH-24-001 | States, Counties, Cities & townships +11 | $28.8M | Dec 1, 2026 |
| Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) National Institutes of Health · RFA-OD-27-008 | States, Counties, Cities & townships +12 | $1.3M | Dec 2, 2026 |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) National Institutes of Health · PAR-24-296 | Others | — | Dec 3, 2026 |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) National Institutes of Health · PAR-24-295 | Others | — | Dec 3, 2026 |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) National Institutes of Health · RFA-OD-24-011 | States, Counties, Cities & townships +12 | — | Dec 4, 2026 |
| Cooperative Research Agreements Related to the World Trade Center Health Program (U01) Centers for Disease Control and Prevention - ERA · RFA-OH-26-001 | States, Counties, Cities & townships +12 | $49.5M | Dec 8, 2026 |